Oventus is proud to announce the launch a new model of the O2Vent Mono – the O2Vent T.
Just like its predecessor, this a custom-made comfortable oral device which is designed for snorers and people with sleep disordered breathing.
The new titratable version (pictured) incorporates a small adjustment key which allows for forward or backward adjustment of the lower jaw to optimise treatment.
The O2Vent T stabilises jaw position and brings the tongue forward to reduce airway collapse. In addition, the unique airway allows for breathing through the device to bypass obstruction in the nose which can contribute to snoring and sleep apnoea.
The device directs airflow through to the back of the throat and bypasses nasal and soft palate obstructions and prevents tongue obstruction.
The improved design makes it especially suitable for patients who experience nasal congestion and who may find CPAP and other oral appliances difficult to use.
Oventus’s latest clinical study1 showed the O2Vent Mono device was successful in treating obstructive sleep apnoea and that snoring was eliminated in 82 per cent of patients and significantly reduced in 100 per cent of the patients.
The O2Vent Mono and the O2Vent T are both entered in the Australian Register of Therapeutic Goods (ARTG 230890 and ARTG 275667) and the O2Vent Mono has $510k clearance (K160234) in the USA.
1Oventus Clinical Trial Report. Data on file.